These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1756327

  • 1. Alpha-interferon broadens the difference between surviving fractions of normal and leukemic progenitor cells in vitro by heat: its application to marrow purging.
    Moriyama Y, Goto T, Nikkuni K, Aoki A, Furukawa T, Narita M, Koyama S, Kishi K, Takahashi M, Shibata A.
    Bone Marrow Transplant; 1991 Oct; 8(4):301-5. PubMed ID: 1756327
    [Abstract] [Full Text] [Related]

  • 2. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J, Fehér I, Kovács P.
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [Abstract] [Full Text] [Related]

  • 3. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J, Fehér I.
    Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
    [Abstract] [Full Text] [Related]

  • 4. Effect of hyperthermia on both primary proliferation and self-renewal of human leukemic progenitor cells in vitro: its application to in vitro purging.
    Moriyama Y, Nikkuni K, Saito H, Aoki A, Kishi K, Takahashi M, Shibata A.
    Leukemia; 1991 Apr; 5(4):332-5. PubMed ID: 2027300
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhanced elimination of Ph+ chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-alpha, TNF, and quercetin): its application to autologous bone marrow transplantation for CML.
    Osman Y, Moriyama Y, Shibata A.
    Exp Hematol; 1995 May; 23(5):444-52. PubMed ID: 7720816
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Killing effect of interleukin-2 and interferon-alpha activated leukemic bone marrow in remission on K562 leukemic cells.
    Li C, Yan W, Hao Y, Han M, Qiu L, Liu H, Han J, Li X, Feng S.
    Chin Med J (Engl); 1999 Jan; 112(1):53-5. PubMed ID: 11593642
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY.
    J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433
    [Abstract] [Full Text] [Related]

  • 13. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec 15; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 14. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation.
    Verdonck LF, Heesbeen EC, van Heugten HG, Staal GE, Rijksen G.
    Bone Marrow Transplant; 1992 Apr 15; 9(4):241-5. PubMed ID: 1600412
    [Abstract] [Full Text] [Related]

  • 15. In vitro purging of clonogenic leukemic cells from human bone marrow by heat: simulation experiments for autologous bone marrow transplantation.
    Moriyama Y, Hashimoto S, Goto T, Furukawa T, Kishi K, Takahashi M, Shibata A.
    Leuk Res; 1992 Oct 15; 16(10):973-7. PubMed ID: 1405711
    [Abstract] [Full Text] [Related]

  • 16. The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging.
    Beran M, Andersson BS, Wang Y, McCredie KB, Farquhar D.
    Cancer Res; 1988 Jan 15; 48(2):339-45. PubMed ID: 3275495
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enhanced selectivity of hyperthermic purging of human progenitor cells using Goralatide, an inhibitor of cell cycle progression.
    Wierenga PK, Brenner MK, Konings AW.
    Bone Marrow Transplant; 1998 Jan 15; 21(1):73-8. PubMed ID: 9486498
    [Abstract] [Full Text] [Related]

  • 19. Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation.
    Allieri MA, Lopez M, Douáy L, Mary JY, NGuyen L, Gorin NC.
    Bone Marrow Transplant; 1991 Feb 15; 7(2):101-5. PubMed ID: 2049553
    [Abstract] [Full Text] [Related]

  • 20. Interferon protects normal human granulocyte/macrophage colony-forming cells from Ara-C cytotoxicity.
    Richman CM, Slapak CA, Toh B.
    J Biol Response Mod; 1990 Dec 15; 9(6):570-5. PubMed ID: 1705960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.